Key Events This Week
2 Mar: Sharp gap down opening amid market concerns
4 Mar: Valuation shifts downgrade price attractiveness
6 Mar: Price rebounds with a 3.17% gain to close the week

Krishna Institute of Medical Sciences Ltd is Rated Sell
2026-03-06 10:11:01Krishna Institute of Medical Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news article
Krishna Institute of Medical Sciences Ltd: Valuation Shifts Signal Price Attractiveness Change
2026-03-04 08:01:35Krishna Institute of Medical Sciences Ltd (KIMS) has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, signals a subtle recalibration in the stock’s price attractiveness amid a challenging hospital sector landscape. Investors should weigh these valuation dynamics against the company’s operational performance and peer comparisons to assess its market positioning.
Read full news article
Krishna Institute of Medical Sciences Ltd Opens with Sharp Gap Down Amid Market Concerns
2026-03-02 09:33:45Krishna Institute of Medical Sciences Ltd (KIMS) commenced trading today with a significant gap down, opening at a price 11.88% lower than its previous close. This weak start reflects heightened market concerns, resulting in notable intraday volatility and a cautious trading environment for the hospital sector stock.
Read full news article
Krishna Institute of Medical Sciences Ltd: Valuation Shifts Signal Heightened Price Risk
2026-02-25 08:01:13Krishna Institute of Medical Sciences Ltd (KIMS) has seen a notable shift in its valuation parameters, moving from an already expensive rating to a very expensive classification. With a price-to-earnings (P/E) ratio soaring to 100.45 and a price-to-book value (P/BV) of 12.93, investors are now faced with a more challenging price attractiveness scenario compared to both historical averages and peer benchmarks within the hospital sector.
Read full news article
Krishna Institute of Medical Sciences Ltd is Rated Sell
2026-02-23 10:11:12Krishna Institute of Medical Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with the latest insights into its performance and outlook.
Read full news article







